Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Hung Hsu

Showing results (11-20 of 242) with videos related to

Pageof 25
Sort By:
World Journal of Gastroenterology|October 1, 2015
Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?Yu-Yun Shao, Chih-Hung Hsu, Ann-Lii Cheng
Anticancer Research|August 5, 2006
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: a two-case studyChia-Chi Lin, Chih-Hung Hsu, Yeong-Shiau Pu
The Oncologist|March 9, 2021
An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular CarcinomaYu-Yun Shao, Ann-Lii Cheng, Chih-Hung Hsu
Liver Cancer|October 26, 2013
Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?Yu-Yun Shao, Chih-Hung Hsu, Ann-Lii Cheng
Toxicology and Applied Pharmacology|September 4, 2020
Arsenic induced epigenetic changes and relevance to treatment of acute promyelocytic leukemia and beyondYasen Maimaitiyiming, Qian Qian Wang, Chih-Hung Hsu, et al.
Plos One|May 12, 2011
UMP/CMPK is not the critical enzyme in the metabolism of pyrimidine ribonucleotide and activation of deoxycytidine analogs in human RKO cellsRong Hu, Wing Lam, Chih-Hung Hsu, et al.
Journal of Zhejiang University. Science. B|July 29, 2025
Small fish making a big difference: beloved star of environmental toxicology research in the current eraYang Jiang, Zhen Su, Jing Zheng, et al.
Esophagus : Official Journal of the Japan Esophageal Society|January 23, 2025
Exploring novel immunotherapy in advanced esophageal squamous cell carcinoma: Is targeting TIGIT an answer?Chien-Huai Chuang, Jhe-Cyuan Guo, Ken Kato, et al.
Liver Cancer|July 8, 2016
Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the ChallengesLi-Chun Lu, Chih-Hung Hsu, Chiun Hsu, et al.
Frontiers in Cell and Developmental Biology|December 27, 2021
Modulation of Phase Separation by RNA: A Glimpse on N<sup>6</sup>-Methyladenosine ModificationYingfeng Su, Yasen Maimaitiyiming, Lingfang Wang, et al.
Pageof 25

Showing results (11-20 of 242) with videos related to

Sort By:
Pageof 25
World Journal of Gastroenterology|October 1, 2015
Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?Yu-Yun Shao, Chih-Hung Hsu, Ann-Lii Cheng
Anticancer Research|August 5, 2006
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: a two-case studyChia-Chi Lin, Chih-Hung Hsu, Yeong-Shiau Pu
The Oncologist|March 9, 2021
An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular CarcinomaYu-Yun Shao, Ann-Lii Cheng, Chih-Hung Hsu
Liver Cancer|October 26, 2013
Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?Yu-Yun Shao, Chih-Hung Hsu, Ann-Lii Cheng
Toxicology and Applied Pharmacology|September 4, 2020
Arsenic induced epigenetic changes and relevance to treatment of acute promyelocytic leukemia and beyondYasen Maimaitiyiming, Qian Qian Wang, Chih-Hung Hsu, et al.
Plos One|May 12, 2011
UMP/CMPK is not the critical enzyme in the metabolism of pyrimidine ribonucleotide and activation of deoxycytidine analogs in human RKO cellsRong Hu, Wing Lam, Chih-Hung Hsu, et al.
Journal of Zhejiang University. Science. B|July 29, 2025
Small fish making a big difference: beloved star of environmental toxicology research in the current eraYang Jiang, Zhen Su, Jing Zheng, et al.
Esophagus : Official Journal of the Japan Esophageal Society|January 23, 2025
Exploring novel immunotherapy in advanced esophageal squamous cell carcinoma: Is targeting TIGIT an answer?Chien-Huai Chuang, Jhe-Cyuan Guo, Ken Kato, et al.
Liver Cancer|July 8, 2016
Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the ChallengesLi-Chun Lu, Chih-Hung Hsu, Chiun Hsu, et al.
Frontiers in Cell and Developmental Biology|December 27, 2021
Modulation of Phase Separation by RNA: A Glimpse on N<sup>6</sup>-Methyladenosine ModificationYingfeng Su, Yasen Maimaitiyiming, Lingfang Wang, et al.
Pageof 25